These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36588448)

  • 1. Assessment of diagnostic and prognostic laboratory biomarkers in severe COVID-19 patients admitted to intensive care unit.
    Fawzy M; Ahmed SS; Abdelhady SA
    Egypt J Immunol; 2023 Jan; 30(1):1-13. PubMed ID: 36588448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones.
    Haroun RA; Osman WH; Amin RE; Eessa AM; Saad S
    Int Immunopharmacol; 2023 Sep; 122():110626. PubMed ID: 37459785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 5. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.
    Ahirwar AK; Takhelmayum R; Sakarde A; Rathod BD; Jha PK; Kumawat R; Gopal N
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):337-344. PubMed ID: 35357792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
    Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
    Punzalan FER; Aherrera JAM; de Paz-Silava SLM; Mondragon AV; Malundo AFG; Tan JJE; Tantengco OAG; Quebral EPB; Uy MNAR; Lintao RCV; Dela Rosa JGL; Mercado MEP; Avenilla KC; Poblete JB; Albay AB; David-Wang AS; Alejandria MM
    Front Immunol; 2023; 14():1123497. PubMed ID: 36926338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
    Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
    BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical laboratory characteristics in patients with suspected COVID-19: One single-institution experience.
    Fei F; Smith JA; Cao L
    J Med Virol; 2021 Mar; 93(3):1665-1671. PubMed ID: 32946118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and early prognostic value of serum CRP and LDH levels in patients with possible COVID-19 at the first admission.
    Akdogan D; Guzel M; Tosun D; Akpinar O
    J Infect Dev Ctries; 2021 Jun; 15(6):766-772. PubMed ID: 34242184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
    Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
    J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics Predicting Mortality Risk in Hospitalized Geriatric Patients with COVID-19 Pneumonia: a Retrospective Study.
    Gulec-Balbay E; Altundal MMB; Kaypak MK; Cangur S; Kaya S
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.
    Shrestha MR; Basnet A; Tamang B; Khadka S; Maharjan R; Maharjan R; Chand AB; Thapa S; Rai SK
    PLoS One; 2023; 18(8):e0287117. PubMed ID: 37540679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
    Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
    Med Clin (Barc); 2021 Apr; 156(7):324-331. PubMed ID: 33422296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status.
    Trofin F; Nastase EV; Roșu MF; Bădescu AC; Buzilă ER; Miftode EG; Manciuc DC; Dorneanu OS
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
    Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
    BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
    Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
    BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.